Skip to main content
. 2017 May 18;17:97. doi: 10.1186/s12883-017-0869-3

Fig. 1.

Fig. 1

Number of headache days (a,) number of headache days with intensity ≥5/10 (b) and number of days with acute medication use (c) by patient satisfaction over the 3-months active treatment period with Cefaly®

HHS Vulnerability Disclosure